CWIAX
Price
$80.54
Change
+$0.71 (+0.89%)
Updated
Jul 31 closing price
Net Assets
157.74B
NUGIX
Price
$36.67
Change
-$0.29 (-0.78%)
Updated
Jul 31 closing price
Net Assets
16.91M
Interact to see
Advertisement

CWIAX vs NUGIX

CWIAX vs NUGIX Comparison Chart in %
View a ticker or compare two or three
VS
CWIAX vs. NUGIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWIAX is a Buy and NUGIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWIAX has more cash in the bank: 158B vs. NUGIX (16.9M). NUGIX pays higher dividends than CWIAX: NUGIX (1.42) vs CWIAX (1.35). CWIAX was incepted earlier than NUGIX: CWIAX (24 years) vs NUGIX (14 years). NUGIX (1.66) is less costly to investors than CWIAX (0.75). CWIAX is a more actively managed with annual turnover of: 44.00 vs. NUGIX (14.00). CWIAX has a lower initial minimum investment than NUGIX: CWIAX (250) vs NUGIX (100000). CWIAX annual gain was more profitable for investors over the last year : 15.58 vs. NUGIX (4.29). CWIAX return over 5 years is better than : 35.78 vs. NUGIX (20.94).
CWIAXNUGIXCWIAX / NUGIX
Total Expense Ratio0.750.9083%
Annual Report Gross Expense Ratio0.751.6645%
Fund Existence24 years14 years-
Gain YTD14.0127.444188%
Front Load4%N/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets158B16.9M934,911%
Annual Yield % from dividends1.351.4295%
Returns for 1 year15.584.29364%
Returns for 3 years44.0722.71194%
Returns for 5 years35.7820.94171%
Returns for 10 years114.6659.41193%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DDDAX25.900.46
+1.81%
13D Activist A
USLIX59.070.76
+1.30%
JHancock U.S. Global Leaders Growth I
HIBCX54.730.46
+0.85%
Hartford Capital Appreciation HLS IB
ADCCX15.880.10
+0.63%
American Century Disciplined Growth C
MFEGX176.711.09
+0.62%
MFS Growth A